Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death.

PubWeight™: 3.09‹?› | Rank: Top 1%

🔗 View Article (PMID 8431943)

Published in Cell on February 12, 1993

Authors

S B Hartley1, M P Cooke, D A Fulcher, A W Harris, S Cory, A Basten, C C Goodnow

Author Affiliations

1: Howard Hughes Medical Institute, Stanford University School of Medicine, California 94305.

Articles citing this

(truncated to the top 100)

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68

The many roles of FAS receptor signaling in the immune system. Immunity (2009) 4.67

Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev (1998) 3.92

Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52

Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med (2003) 2.77

Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci U S A (1994) 2.66

Control systems and decision making for antibody production. Nat Immunol (2010) 2.60

Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci U S A (2005) 2.43

Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood (2006) 2.32

Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med (1995) 2.26

Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol (1996) 2.17

Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J (1994) 2.16

Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol (1995) 2.10

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96

The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med (1998) 1.88

Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85

Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med (1994) 1.83

bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med (1996) 1.79

Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest (2002) 1.76

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68

B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66

Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63

A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med (1996) 1.58

Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49

Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J Exp Med (1999) 1.44

A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc Natl Acad Sci U S A (2000) 1.42

Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc Natl Acad Sci U S A (1997) 1.42

CD5 maintains tolerance in anergic B cells. J Exp Med (2000) 1.42

Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41

Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. EMBO J (1995) 1.39

Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J Immunol (2013) 1.39

STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol (2011) 1.37

Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33

MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33

CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med (1997) 1.26

Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κB. J Exp Med (2013) 1.26

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls. J Immunol (2011) 1.25

Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med (1999) 1.23

BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development. Cell Death Differ (2008) 1.23

The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med (1993) 1.17

Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity (2008) 1.14

Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol (2009) 1.12

Role of Syk in B-cell development and antigen-receptor signaling. Proc Natl Acad Sci U S A (2000) 1.11

Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization. Immunity (1999) 1.10

Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate. Proc Natl Acad Sci U S A (2000) 1.09

Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09

Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07

B cells and autoimmunity. Curr Opin Immunol (2011) 1.06

S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. Eur J Immunol (2010) 1.04

Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J Exp Med (2000) 1.04

Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. J Exp Med (1998) 1.02

A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J (1994) 1.02

Loss of the proapoptotic protein, Bim, breaks B cell anergy. J Exp Med (2006) 1.01

Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc Natl Acad Sci U S A (1995) 1.00

Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. Proc Natl Acad Sci U S A (1998) 1.00

Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation. Arthritis Rheum (2013) 0.97

B cells and transplantation tolerance. Nat Rev Nephrol (2010) 0.97

Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol Cell Biol (1995) 0.96

The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. EMBO J (1996) 0.96

Fragmented inositol 1,4,5-trisphosphate receptors retain tetrameric architecture and form functional Ca2+ release channels. J Biol Chem (2013) 0.94

A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells. Immunology (1995) 0.94

Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells. Immunology (2004) 0.93

Central B-cell tolerance: where selection begins. Cold Spring Harb Perspect Biol (2012) 0.92

Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods (2010) 0.92

Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright. J Immunol (2007) 0.92

Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice. Immunology (2002) 0.90

A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway. J Exp Med (2003) 0.90

Lasting antibody responses are mediated by a combination of newly formed and established bone marrow plasma cells drawn from clonally distinct precursors. J Immunol (2014) 0.89

The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med (2003) 0.89

CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools. Proc Natl Acad Sci U S A (2000) 0.88

The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Mol Immunol (2011) 0.88

Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape. J Immunol (2011) 0.87

Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc Natl Acad Sci U S A (1997) 0.86

Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes. J Immunol (2014) 0.85

Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes. J Exp Med (1998) 0.85

CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow. J Exp Med (2014) 0.85

Antigen and cytokine receptor signals guide the development of the naïve mature B cell repertoire. Immunol Res (2013) 0.85

Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells. PLoS One (2013) 0.84

The integration hypothesis: an evolutionary pathway to benign SIV infection. PLoS Pathog (2006) 0.84

Piecing together the humoral and cellular mechanisms of immune thrombocytopenia. Semin Thromb Hemost (2011) 0.84

Rescue of self-reactive B cells by provision of T cell help in vivo. Eur J Immunol (1998) 0.84

Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun (2016) 0.84

Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition. J Immunol (2013) 0.82

B-cell-activating factor and autoimmune myasthenia gravis. Autoimmune Dis (2011) 0.82

Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity? Curr Opin Immunol (2014) 0.81

Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis. Clin Exp Immunol (1999) 0.81

Mechanisms of central tolerance for B cells. Nat Rev Immunol (2017) 0.81

B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One (2010) 0.80

Receptor editing and genetic variability in human autoreactive B cells. J Exp Med (2015) 0.79

Autoantibodies: Focus on anti-DNA antibodies. Self Nonself (2011) 0.79

Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H-2b alloantigens. J Exp Med (1996) 0.79

Therapeutic CD154 antibody for lupus: promise for the future? J Clin Invest (2003) 0.79

Historical overview of immunological tolerance. Cold Spring Harb Perspect Biol (2012) 0.79

Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses. J Virol (2016) 0.78

B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals. Clin Exp Immunol (2006) 0.78

Signal transduction through mu kappa B-cell receptors expressed on pre-B cells is different from that through B-cell receptors on mature B cells. Immunology (1996) 0.77

Effect of early fetal splenectomy on prenatal B-cell development in sheep. Immunology (2001) 0.77

Articles by these authors

The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56

The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene (2007) 10.08

Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature (1997) 9.99

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J (1998) 7.17

Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63

Mouse myelomas and lymphomas in culture. Exp Cell Res (1970) 5.12

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68

A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell (1984) 4.41

Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36

A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell (2001) 4.36

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35

Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell (1994) 4.22

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04

Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02

The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell (1986) 3.72

Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J (1985) 3.68

CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. J Clin Invest (1939) 3.46

Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A (1999) 3.45

Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40

Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U S A (1983) 3.40

Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell (1992) 3.17

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci (2001) 3.03

Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell (2001) 3.03

Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA. Nature (1975) 2.97

Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature (1995) 2.95

Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J (1994) 2.91

Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes. Cell (1980) 2.89

Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res (1986) 2.84

A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J (1998) 2.82

Nucleotide sequence of N-formyl-methionyl-transfer RNA. Nature (1968) 2.82

Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. Proc Natl Acad Sci U S A (1980) 2.77

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene (1997) 2.70

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61

Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell (1984) 2.60

Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57

Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity (1995) 2.55

Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45

CLINICAL STUDIES OF THE BLOOD VOLUME. VIII. MACROCYTIC AND HYPOCHROMIC ANEMIAS DUE TO CHRONIC BLOOD LOSS, HEMOLYSIS AND MISCELLANEOUS CAUSES, AND POLYCYTHEMIA VERA. J Clin Invest (1939) 2.45

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J (1997) 2.44

Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity (1998) 2.42

A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes. Cell (1977) 2.42

Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40

Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity (1997) 2.34

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30

bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene (1993) 2.25

Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23

Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature (1985) 2.19

Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16

Transgenic models of tumor development. Science (1991) 2.16

Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15

Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol (1972) 2.15

Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol (1973) 2.14

A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J (1989) 2.13

Translation of immunoglobulin mRNAs in a wheat germ cell-free system. Mol Biol Rep (1974) 2.11

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell (1996) 2.09

Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood (1999) 2.06

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J (1990) 2.00

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00

Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome. Intern Med J (2014) 2.00

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98

Self-tolerance checkpoints in B lymphocyte development. Adv Immunol (1995) 1.97

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97

Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression. Nature (1980) 1.96

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96

Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96

Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A (1998) 1.95

Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94

Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes. J Mol Appl Genet (1981) 1.93

Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med (1995) 1.91

A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90

B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol Rev (2000) 1.89

Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development. Proc Natl Acad Sci U S A (1980) 1.89

Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev (1996) 1.89

Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity (1995) 1.88

Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88